Reports for APOTEX INC
Company Name
APOTEX INC
Totals |
||
Shortage reports |
3077 |
|
| Actual shortage: | 235 (8%) | |
| Anticipated shortage: | 16 (1%) | |
| Avoided shortage: | 9 (0%) | |
| Resolved: | 2817 (92%) | |
Discontinuation Reports |
356 |
|
| To be discontinued: | 22 (6%) | |
| Discontinued: | 334 (94%) | |
| Reversed: | 0 (0%) | |
Late reports |
142 (4%) |
|
Overdue reports |
31 (11%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-06-23 | 2023-08-23 | 196297 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-09-07 | 2023-10-20 | 203804 |
| APO-METHYLPHENIDATE ER | 18MG | TABLET (EXTENDED-RELEASE) | Resolved | 2023-11-06 | 2024-04-19 | 209298 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2017-09-06 | 2018-09-11 | 21096 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2019-03-27 | 2019-03-29 | 79574 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2020-01-22 | 2020-03-09 | 103923 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2020-05-13 | 2020-05-19 | 114937 |
| APO-TRYPTOPHAN | 1G | TABLET | Resolved | 2021-02-05 | 2021-04-12 | 133391 |
| APO-TRYPTOPHAN | 1G | TABLET | Resolved | 2022-01-21 | 2022-03-09 | 153294 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2022-04-08 | 2022-08-24 | 158348 |
| APO-SUCRALFATE - TAB 1G | 1G | TABLET | Resolved | 2022-09-09 | 2023-09-22 | 169045 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Resolved | 2024-01-19 | 2024-02-09 | 216672 |
| APO-TRYPTOPHAN | 1G | TABLET | Resolved | 2024-02-23 | 2024-04-05 | 220468 |
| APO-CEFEPIME | 1G | POWDER FOR SOLUTION | Actual shortage | 2024-05-03 | 2024-06-07 | 227082 |
| APO-VARENICLINE | 1MG 0.5MG | TABLET KIT | Actual shortage | 2021-11-29 | 2021-11-29 | 150175 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 55 |
| APO-CILAZAPRIL | 1MG | TABLET | Resolved | 2017-03-10 | 2017-04-04 | 80 |
| APO-RASAGILINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-03-28 | 472 |
| APO-TOLTERODINE | 1MG | TABLET | Resolved | 2017-03-11 | 2017-11-08 | 516 |
| APO-ANASTROZOLE | 1MG | TABLET | Resolved | 2017-04-07 | 2017-12-11 | 5888 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-02-23 | 2018-07-17 | 40763 | ||
| APO-CETIRIZINE | Discontinued | 2018-05-31 | 2018-05-31 | 50998 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-09-07 | 2018-09-15 | 60241 | ||
| APO-CYCLOSPORINE ORAL SOLUTION | Discontinued | 2018-09-07 | 2018-09-15 | 60408 | ||
| APO-FAMOTIDINE TAB 20MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60477 | ||
| APO-FAMOTIDINE TAB 40MG USP | Discontinued | 2018-09-07 | 2018-09-15 | 60480 | ||
| APO-FENTANYL MATRIX | Discontinued | 2018-09-07 | 2018-09-15 | 60494 | ||
| APO-IRBESARTAN/HCTZ | Discontinued | 2018-09-07 | 2018-09-15 | 60548 | ||
| APO-LATANOPROST-TIMOP | Discontinued | 2018-09-07 | 2018-09-15 | 60572 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60735 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60738 | ||
| APO-REPAGLINIDE | Discontinued | 2018-09-08 | 2018-09-15 | 60741 | ||
| APO-RIZATRIPTAN RPD | Discontinued | 2018-09-08 | 2019-04-02 | 60756 | ||
| APO-SILDENAFIL R | Discontinued | 2018-09-08 | 2018-09-15 | 60787 | ||
| APO-AMOXI CLAV 125MG/31.25MG PER 5ML | Discontinued | 2018-12-21 | 2018-12-24 | 70347 | ||
| APO-TIMOP | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| ACID CONTROL | Discontinued | 2019-01-03 | 2019-01-03 | 70906 | ||
| APO-OFLOXACIN | Discontinued | 2019-01-03 | 2019-01-03 | 71017 | ||
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 |